{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T01:18:14Z","timestamp":1793927894319,"version":"4.8.0"},"reference-count":127,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T00:00:00Z","timestamp":1710979200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005270","name":"Fujian Provincial Department of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005270","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2023J011188"],"award-info":[{"award-number":["2023J011188"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2020J011094"],"award-info":[{"award-number":["2020J011094"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.eclinm.2024.102589","type":"journal-article","created":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T15:56:54Z","timestamp":1712246214000},"page":"102589","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Effectiveness and safety of tetracyclines and quinolones in people with Mycoplasma pneumonia: a systematic review and network meta-analysis"],"prefix":"10.1016","volume":"71","author":[{"given":"Fangqing","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinglin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijie","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6462-2357","authenticated-orcid":false,"given":"Junshan","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.eclinm.2024.102589_bib1","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2022.27.19.2100746","article-title":"Mycoplasma pneumoniae detections before and during the COVID-19 pandemic: results of a global survey, 2017 to 2021","volume":"27","author":"Meyer Sauteur","year":"2022","journal-title":"Euro Surveill"},{"issue":"2","key":"10.1016\/j.eclinm.2024.102589_bib2","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1016\/S2666-5247(23)00344-0","article-title":"Mycoplasma pneumoniae: delayed re-emergence after COVID-19 pandemic restrictions","volume":"5","author":"Meyer Sauteur","year":"2023","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.eclinm.2024.102589_bib3","doi-asserted-by":"crossref","first-page":"974","DOI":"10.3389\/fmicb.2016.00974","article-title":"Mycoplasma pneumoniae: current knowledge on macrolide resistance and treatment","volume":"7","author":"Pereyre","year":"2016","journal-title":"Front Microbiol"},{"issue":"6","key":"10.1016\/j.eclinm.2024.102589_bib4","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.3201\/eid2706.203206","article-title":"Macrolide-resistant mycoplasma pneumoniae infections in children, Ohio, USA","volume":"27","author":"Lanata","year":"2021","journal-title":"Emerg Infect Dis"},{"issue":"7","key":"10.1016\/j.eclinm.2024.102589_bib5","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.20949","article-title":"Global trends in the proportion of macrolide-resistant mycoplasma pneumoniae infections: a systematic review and meta-analysis","volume":"5","author":"Kim","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.eclinm.2024.102589_bib6","article-title":"Increased macrolide resistance rate of M3562 mycoplasma pneumoniae correlated with macrolide usage and genotype shifting","volume":"11","author":"Wang","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102589_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0170253","article-title":"Changes in molecular characteristics of mycoplasma pneumoniae in clinical specimens from children in Beijing between 2003 and 2015","volume":"12","author":"Sun","year":"2017","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.eclinm.2024.102589_bib8","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1002\/ppul.24327","article-title":"Molecular and clinical characteristics of severe Mycoplasma pneumoniae pneumonia in children","volume":"54","author":"Yan","year":"2019","journal-title":"Pediatr Pulmonol"},{"issue":"3","key":"10.1016\/j.eclinm.2024.102589_bib9","doi-asserted-by":"crossref","first-page":"811","DOI":"10.3390\/idr13030073","article-title":"Update on the epidemiology of macrolide-resistant mycoplasma pneumoniae in Europe: a systematic review","volume":"13","author":"Loconsole","year":"2021","journal-title":"Infect Dis Rep"},{"issue":"2","key":"10.1016\/j.eclinm.2024.102589_bib10","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1469-0691.2007.01834.x","article-title":"Mycoplasma pneumoniae-an emerging extra-pulmonary pathogen","volume":"14","author":"S\u00e1nchez-Vargas","year":"2008","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"10.1016\/j.eclinm.2024.102589_bib11","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4103\/0970-2113.63611","article-title":"Mycoplasma pneumonia: clinical features and management","volume":"27","author":"Kashyap","year":"2010","journal-title":"Lung India"},{"issue":"4","key":"10.1016\/j.eclinm.2024.102589_bib12","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1055\/s-0031-1271717","article-title":"Mycoplasma pneumoniae-associated encephalitis in childhood--nervous system disorder during or after a respiratory tract infection","volume":"223","author":"Meyer Sauteur","year":"2011","journal-title":"Klin Padiatr"},{"issue":"6","key":"10.1016\/j.eclinm.2024.102589_bib13","first-page":"1154","article-title":"Predictive factors of the responses to treatment of mycoplasma pneumoniae pneumonia","volume":"10","author":"Lee","year":"2021","journal-title":"J\u00a0Clin Med"},{"issue":"6","key":"10.1016\/j.eclinm.2024.102589_bib14","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1002\/ppul.25298","article-title":"Cases of macrolide-resistant Mycoplasma pneumoniae pneumonia-associated pulmonary thromboembolism","volume":"56","author":"Kim","year":"2021","journal-title":"Pediatr Pulmonol"},{"issue":"5","key":"10.1016\/j.eclinm.2024.102589_bib15","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1086\/516119","article-title":"Quinolone arthropathy in animals versus children","volume":"25","author":"Burkhardt","year":"1997","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.eclinm.2024.102589_bib16","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1542\/peds.47.3.567","article-title":"Tetracyclines and permanent teeth: the relation between dose and tooth color","volume":"47","author":"Grossman","year":"1971","journal-title":"Pediatrics"},{"issue":"7","key":"10.1016\/j.eclinm.2024.102589_bib17","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1093\/cid\/cir531","article-title":"The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America","volume":"53","author":"Bradley","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.eclinm.2024.102589_bib18","first-page":"291","article-title":"Diagnosis and treatment guidelines for mycoplasma pneumonia in children (2023 edition)","volume":"36","author":"Shunying","year":"2023","journal-title":"Infect Dis Inform"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102589_bib19","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1186\/s12879-021-06508-7","article-title":"Efficacy of tetracyclines and fluoroquinolones for the treatment of macrolide-refractory Mycoplasma pneumoniae pneumonia in children: a systematic review and meta-analysis","volume":"21","author":"Ahn","year":"2021","journal-title":"BMC Infect Dis"},{"issue":"6","key":"10.1016\/j.eclinm.2024.102589_bib20","doi-asserted-by":"crossref","first-page":"3399","DOI":"10.21037\/jtd-20-2256","article-title":"Fluoroquinolone and no risk of Achilles-tendinopathy in childhood pneumonia under eight years of age-a nationwide retrospective cohort","volume":"13","author":"Kim","year":"2021","journal-title":"J\u00a0Thorac Dis"},{"key":"10.1016\/j.eclinm.2024.102589_bib21","series-title":"Cochrane handbook for systematic reviews of interventions version 6.3","author":"Higgins","year":"2022"},{"issue":"11","key":"10.1016\/j.eclinm.2024.102589_bib22","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations","volume":"162","author":"Hutton","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.eclinm.2024.102589_bib23","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.eclinm.2024.102589_bib24","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.eclinm.2024.102589_bib25","series-title":"The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses","author":"Wells","year":"2011"},{"issue":"4","key":"10.1016\/j.eclinm.2024.102589_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003082","article-title":"CINeMA: an approach for assessing confidence in the results of a network meta-analysis","volume":"17","author":"Nikolakopoulou","year":"2020","journal-title":"PLoS Med"},{"issue":"7650","key":"10.1016\/j.eclinm.2024.102589_bib27","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE Working Group. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.eclinm.2024.102589_bib28","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/jrsm.1054","article-title":"Automating network meta-analysis","volume":"3","author":"van Valkenhoef","year":"2012","journal-title":"Res Synth Methods"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102589_bib29","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s12874-019-0829-2","article-title":"BUGSnet: an R package to facilitate the conduct and reporting of bayesian network meta-analyses","volume":"19","author":"B\u00e9liveau","year":"2019","journal-title":"BMC Med Res Methodol"},{"issue":"37","key":"10.1016\/j.eclinm.2024.102589_bib30","first-page":"7450","article-title":"Analysis of the efficacy and mechanism of action of azithromycin and levofloxacin in the clinical treatment of Mycoplasma pneumonia","volume":"3","author":"Jiangrui","year":"2016","journal-title":"Electron J Clin Med Literature"},{"issue":"9","key":"10.1016\/j.eclinm.2024.102589_bib31","first-page":"127","article-title":"Comparison of therapeutic effects between azithromycin and moxifloxacin in the treatment of adult mycoplasma pneumonia","volume":"29","author":"Xiaolin","year":"2015","journal-title":"Cont Med Educ"},{"issue":"9","key":"10.1016\/j.eclinm.2024.102589_bib32","first-page":"138","article-title":"Observation on the therapeutic effect and safety analysis of azithromycin and levofloxacin in the treatment of adult mycoplasma pneumonia","volume":"14","author":"Jiaying","year":"2020","journal-title":"Chinese J Modern Drug Appl"},{"issue":"2","key":"10.1016\/j.eclinm.2024.102589_bib33","first-page":"150","article-title":"Efficacy and safety analysis of azithromycin and levofloxacin in the treatment of adult mycoplasma pneumonia","volume":"7","author":"Hongmei","year":"2020","journal-title":"Electron J Gen Stomatol"},{"issue":"10","key":"10.1016\/j.eclinm.2024.102589_bib34","first-page":"148","article-title":"Efficacy and safety analysis of azithromycin and levofloxacin in the treatment of adult mycoplasma pneumonia","volume":"13","author":"Liqing","year":"2016","journal-title":"J\u00a0North Pharm"},{"key":"10.1016\/j.eclinm.2024.102589_bib35","first-page":"153","article-title":"Observation on the efficacy and safety of azithromycin and levofloxacin in the treatment of adult Mycoplasma pneumonia","volume":"4","author":"Zongliang","year":"2021","journal-title":"Renowned Doctor"},{"issue":"5","key":"10.1016\/j.eclinm.2024.102589_bib36","first-page":"103","article-title":"Clinical value of azithromycin and levofloxacin in the treatment of adult Mycoplasma pneumonia","volume":"12","author":"Yiping","year":"2021","journal-title":"China Health Stand Manag"},{"key":"10.1016\/j.eclinm.2024.102589_bib37","first-page":"134","article-title":"Comparison of the therapeutic effects of macrolide antibiotics and quinolone antibiotics on adult Mycoplasma pneumoniae pneumonia","volume":"2","author":"Sheng","year":"2018","journal-title":"Renowned Doctor"},{"issue":"22","key":"10.1016\/j.eclinm.2024.102589_bib38","first-page":"51","article-title":"The effect of moxifloxacin treatment on adult Mycoplasma pneumonia and its impact on lung function indicators","volume":"37","author":"Xueyan","year":"2021","journal-title":"Chinese Commun Doctors"},{"issue":"59","key":"10.1016\/j.eclinm.2024.102589_bib39","article-title":"Comparative analysis of the value of using azithromycin and levofloxacin in the treatment of adult Mycoplasma pneumonia","volume":"3","author":"Weiwei","year":"2016","journal-title":"Electron J Clin Med Literature"},{"key":"10.1016\/j.eclinm.2024.102589_bib40","first-page":"213","article-title":"Clinical observation on the treatment effect of moxifloxacin on adult Mycoplasma pneumoniae pneumonia","volume":"39","author":"Hongwei","year":"2015","journal-title":"J\u00a0Med Inform"},{"issue":"11","key":"10.1016\/j.eclinm.2024.102589_bib41","first-page":"64","article-title":"Analysis of the clinical efficacy of moxifloxacin in the treatment of adult Mycoplasma pneumonia","volume":"5","author":"Peijun","year":"2020","journal-title":"Syst Med"},{"key":"10.1016\/j.eclinm.2024.102589_bib42","first-page":"17","article-title":"Comparative study of ciprofloxacin and erythromycin in the treatment of Mycoplasma pneumonia","volume":"1","author":"Guoqiang","year":"1998","journal-title":"Hebei Med"},{"key":"10.1016\/j.eclinm.2024.102589_bib43","first-page":"2980","article-title":"Observation on the therapeutic effect of gatifloxacin in the treatment of Mycoplasma pneumoniae infection","volume":"22","author":"Ping","year":"2004","journal-title":"Modern J Intergr Trad Chinese Western Med"},{"issue":"31","key":"10.1016\/j.eclinm.2024.102589_bib44","first-page":"6","article-title":"Comparison of moxifloxacin and azithromycin in the treatment of Mycoplasma pneumoniae infection","volume":"46","author":"Ping","year":"2008","journal-title":"China Modern Doctor"},{"issue":"19","key":"10.1016\/j.eclinm.2024.102589_bib45","first-page":"79","article-title":"Comparison of clinical efficacy between moxifloxacin and azithromycin in the treatment of adult Mycoplasma pneumonia","volume":"14","author":"Cheng","year":"2021","journal-title":"Chinese J Clin Ration Drug Use"},{"issue":"8","key":"10.1016\/j.eclinm.2024.102589_bib46","first-page":"183","article-title":"Clinical efficacy of moxifloxacin and azithromycin in the treatment of adult Mycoplasma pneumonia","volume":"8","author":"Hongjie","year":"2022","journal-title":"World J Complex Med"},{"issue":"25","key":"10.1016\/j.eclinm.2024.102589_bib47","first-page":"18","article-title":"Comparative observation of clinical efficacy between moxifloxacin and azithromycin in the treatment of Mycoplasma pneumonia","volume":"7","author":"Jv","year":"2014","journal-title":"Chinese J Clin Ration Drug Use"},{"issue":"12","key":"10.1016\/j.eclinm.2024.102589_bib48","first-page":"1875","article-title":"Clinical efficacy of moxifloxacin in the treatment of 108 cases of adult Mycoplasma pneumonia","volume":"16","author":"Yunhu","year":"2011","journal-title":"J\u00a0Clin Pulmon Med"},{"issue":"28","key":"10.1016\/j.eclinm.2024.102589_bib49","first-page":"57","article-title":"Observation on the efficacy of moxifloxacin in the treatment of adult Mycoplasma pneumoniae pneumonia","volume":"8","author":"Guofeng","year":"2010","journal-title":"Guide China Med"},{"issue":"35","key":"10.1016\/j.eclinm.2024.102589_bib50","first-page":"115","article-title":"Analysis of the efficacy of moxifloxacin in the treatment of adult Mycoplasma pneumoniae pneumonia","volume":"14","author":"Li","year":"2019","journal-title":"China Pract Med"},{"issue":"14","key":"10.1016\/j.eclinm.2024.102589_bib51","first-page":"2733","article-title":"Analysis of the therapeutic effect of moxifloxacin on adult Mycoplasma pneumonia","volume":"2","author":"Haixia","year":"2015","journal-title":"Electron J Clin Med Literature"},{"issue":"6","key":"10.1016\/j.eclinm.2024.102589_bib52","first-page":"134","article-title":"Observation on the efficacy of moxifloxacin in the treatment of adult Mycoplasma pneumonia","volume":"14","author":"Wei","year":"2020","journal-title":"Chinese J Modern Drug Appl"},{"issue":"8","key":"10.1016\/j.eclinm.2024.102589_bib53","first-page":"35","article-title":"Clinical observation of moxifloxacin in the treatment of adult Mycoplasma pneumonia","volume":"23","author":"Shaoming","year":"2016","journal-title":"Guangdong Trace Elem Sci"},{"issue":"6","key":"10.1016\/j.eclinm.2024.102589_bib54","first-page":"208","article-title":"Clinical efficacy analysis of moxifloxacin in the treatment of adult Mycoplasma pneumonia","volume":"15","author":"Tingting","year":"2020","journal-title":"Psychol Mag"},{"issue":"8","key":"10.1016\/j.eclinm.2024.102589_bib55","first-page":"100","article-title":"Clinical efficacy analysis of moxifloxacin in the treatment of adult Mycoplasma pneumonia","volume":"12","author":"Yuqin","year":"2014","journal-title":"Guide China Med"},{"issue":"5","key":"10.1016\/j.eclinm.2024.102589_bib56","first-page":"73","article-title":"Clinical efficacy analysis of moxifloxacin in the treatment of adult Mycoplasma pneumonia","volume":"37","author":"Hongying","year":"2017","journal-title":"Clin Med"},{"issue":"15","key":"10.1016\/j.eclinm.2024.102589_bib57","first-page":"2985","article-title":"Clinical efficacy analysis of moxifloxacin in the treatment of adult Mycoplasma pneumonia","volume":"3","author":"Xiang","year":"2016","journal-title":"Electron J Clin Med Literature"},{"issue":"3","key":"10.1016\/j.eclinm.2024.102589_bib58","first-page":"2250","article-title":"Clinical efficacy evaluation of moxifloxacin in the treatment of adult Mycoplasma pneumonia","volume":"29","author":"Xiuqing","year":"2016","journal-title":"Med J Thepresent Clin"},{"issue":"50","key":"10.1016\/j.eclinm.2024.102589_bib59","first-page":"169","article-title":"Clinical efficacy analysis of moxifloxacin in the treatment of adult Mycoplasma pneumonia","volume":"5","author":"Rui","year":"2018","journal-title":"Electron J Clin Med Literature"},{"issue":"8","key":"10.1016\/j.eclinm.2024.102589_bib60","first-page":"131","article-title":"Clinical observation of moxifloxacin in the treatment of adult Mycoplasma pneumonia","volume":"24","author":"Wenxian","year":"2015","journal-title":"Henan Med Res"},{"issue":"19","key":"10.1016\/j.eclinm.2024.102589_bib61","first-page":"143+179","article-title":"Clinical study of moxifloxacin in the treatment of adult mycoplasma pneumonia","volume":"19","author":"Xiaoqiang","year":"2019","journal-title":"World Latest Med Inform"},{"issue":"89","key":"10.1016\/j.eclinm.2024.102589_bib62","first-page":"89+92","article-title":"Analysis of the efficacy of moxifloxacin in the treatment of adult Mycoplasma pneumonia","volume":"18","author":"Yange","year":"2018","journal-title":"World Latest Med Inform"},{"issue":"7","key":"10.1016\/j.eclinm.2024.102589_bib63","first-page":"100","article-title":"Clinical observation on moxifloxacin in the treatment of 40 cases of elderly mycoplasma pneumonia","volume":"25","author":"Yilu","year":"2016","journal-title":"Chin J Ethnomed Ethnopharmacy"},{"issue":"18","key":"10.1016\/j.eclinm.2024.102589_bib64","first-page":"3551","article-title":"Clinical efficacy analysis of moxifloxacin in the treatment of elderly patients with Mycoplasma pneumonia","volume":"16","author":"Shimin","year":"2016","journal-title":"Prog Mod Biomed"},{"issue":"3","key":"10.1016\/j.eclinm.2024.102589_bib65","first-page":"318","article-title":"Clinical efficacy of moxifloxacin in the treatment of Mycoplasma pneumoniae pneumonia in young people","volume":"28","author":"Xian","year":"2015","journal-title":"Chinese J Clin Res"},{"issue":"92","key":"10.1016\/j.eclinm.2024.102589_bib66","first-page":"18154","article-title":"Clinical efficacy analysis of moxifloxacin in the treatment of Mycoplasma pneumoniae pneumonia in young people","volume":"4","author":"Baoqi","year":"2017","journal-title":"Electron J Clin Med Literature"},{"issue":"4","key":"10.1016\/j.eclinm.2024.102589_bib67","first-page":"94","article-title":"Analysis of the therapeutic effect of moxifloxacin on 65 cases of Mycoplasma pneumonia","volume":"35","author":"Lisheng","year":"2013","journal-title":"Fujian Med J"},{"issue":"13","key":"10.1016\/j.eclinm.2024.102589_bib68","first-page":"2590","article-title":"Clinical efficacy of moxifloxacin in the treatment of Mycoplasma pneumonia","volume":"38","author":"Zaiqiang","year":"2011","journal-title":"Mod Prev Med"},{"issue":"27","key":"10.1016\/j.eclinm.2024.102589_bib69","first-page":"90","article-title":"Clinical efficacy of moxifloxacin in the treatment of Mycoplasma pneumonia","volume":"13","author":"Ting","year":"2018","journal-title":"China Pract Med"},{"issue":"S2","key":"10.1016\/j.eclinm.2024.102589_bib70","first-page":"3","article-title":"Clinical efficacy analysis of moxifloxacin in the treatment of Mycoplasma pneumonia","volume":"10","author":"Xvlin","year":"2015","journal-title":"China J Pharm Econ"},{"issue":"21","key":"10.1016\/j.eclinm.2024.102589_bib71","first-page":"2604","article-title":"Observation on the therapeutic effect of moxifloxacin in the treatment of Mycoplasma pneumonia","volume":"46","author":"Dongxia","year":"2017","journal-title":"Shanxi Med J"},{"issue":"11","key":"10.1016\/j.eclinm.2024.102589_bib72","first-page":"112","article-title":"Clinical efficacy and analysis of moxifloxacin in the treatment of Mycoplasma pneumoniae pneumonia in middle-aged and young adults","volume":"30","author":"Xinyan","year":"2018","journal-title":"Strait Pharm J"},{"issue":"95","key":"10.1016\/j.eclinm.2024.102589_bib73","first-page":"107","article-title":"Exploring the clinical efficacy of moxifloxacin in the treatment of adult Mycoplasma pneumoniae pneumonia","volume":"20","author":"Kangrong","year":"2020","journal-title":"World Latest Med Inform"},{"issue":"15","key":"10.1016\/j.eclinm.2024.102589_bib74","first-page":"2939","article-title":"A\u00a0study on the treatment of refractory mycoplasma pneumonia in children with quinolones","volume":"14","author":"Dan","year":"2014","journal-title":"Prog Mod Biomed"},{"issue":"2","key":"10.1016\/j.eclinm.2024.102589_bib75","first-page":"225","article-title":"Clinical efficacy analysis of neofluoroquinolone antibiotics in the treatment of Mycoplasma pneumonia","volume":"8","author":"Qun","year":"2014","journal-title":"For All Health"},{"key":"10.1016\/j.eclinm.2024.102589_bib76","first-page":"576","article-title":"Observation on the therapeutic effect of levofloxacin hydrochloride in the treatment of Mycoplasma pneumonia","volume":"3","author":"Jin","year":"2008","journal-title":"Chin J Misdiagn"},{"issue":"70","key":"10.1016\/j.eclinm.2024.102589_bib77","first-page":"13801","article-title":"The effect of moxifloxacin treatment on elderly patients with Mycoplasma pneumonia","volume":"4","author":"Danhong","year":"2017","journal-title":"Electron J Clin Med Literature"},{"issue":"28","key":"10.1016\/j.eclinm.2024.102589_bib78","first-page":"2619","article-title":"Observation on the therapeutic effect of levofloxacin and azithromycin in the treatment of Mycoplasma pneumonia","volume":"21","author":"Sijing","year":"2010","journal-title":"China Pharm"},{"issue":"11","key":"10.1016\/j.eclinm.2024.102589_bib79","first-page":"87","article-title":"Observation on the therapeutic effect of levofloxacin in the treatment of 30 elderly patients with Mycoplasma pneumoniae pneumonia","volume":"16","author":"Aizhi","year":"2009","journal-title":"China Modern Med"},{"issue":"S2","key":"10.1016\/j.eclinm.2024.102589_bib80","first-page":"19","article-title":"The application of doxycycline in the treatment of Mycoplasma pneumonia","volume":"12","author":"Hongfa","year":"2012","journal-title":"Mod Hosp"},{"issue":"21","key":"10.1016\/j.eclinm.2024.102589_bib81","first-page":"121","article-title":"Evaluation of the efficacy of doxycycline in the treatment of macrolide resistant mycoplasma pneumonia in children","volume":"54","author":"Hongzhou","year":"2016","journal-title":"China Modern Doctor"},{"issue":"4","key":"10.1016\/j.eclinm.2024.102589_bib82","first-page":"64","article-title":"Clinical observation of minocycline hydrochloride in the treatment of Mycoplasma pneumoniae pneumonia in children","volume":"14","author":"Xue","year":"2013","journal-title":"Chinese Med Rec"},{"issue":"12","key":"10.1016\/j.eclinm.2024.102589_bib83","first-page":"1703","article-title":"Moxifloxacin in the treatment of 200 cases of community acquired pneumonia","volume":"17","author":"Xiaodong","year":"2010","journal-title":"Chinese J Prim Med Pharm"},{"key":"10.1016\/j.eclinm.2024.102589_bib84","first-page":"54","article-title":"Randomly controlled treatment of 53 cases of mycoplasma pneumonia with sparfloxacin and erythromycin","volume":"3","author":"Min","year":"2001","journal-title":"Tianjin Pharm"},{"issue":"5","key":"10.1016\/j.eclinm.2024.102589_bib85","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1128\/AAC.00048-13","article-title":"Therapeutic efficacy of macrolides, minocycline, and tosufloxacin against macrolide-resistant Mycoplasma pneumoniae pneumonia in pediatric patients","volume":"57","author":"Kawai","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"10.1016\/j.eclinm.2024.102589_bib86","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1183\/09031936.95.08121999","article-title":"Treatment of community-acquired pneumonia: a randomized comparison of sparfloxacin, amoxycillin-clavulanic acid and erythromycin","volume":"8","author":"Lode","year":"1995","journal-title":"Eur Respir J"},{"issue":"23","key":"10.1016\/j.eclinm.2024.102589_bib87","first-page":"56+69","article-title":"Comparison of therapeutic effects between azithromycin and levofloxacin in the treatment of adult Mycoplasma pneumonia","volume":"18","author":"Mei","year":"2020","journal-title":"Med Diet Health"},{"key":"10.1016\/j.eclinm.2024.102589_bib88","first-page":"50","article-title":"Observation on the therapeutic effect of ciprofloxacin in the treatment of Mycoplasma pneumonia","volume":"2","author":"Jihong","year":"2001","journal-title":"Chinese Med J Metallurg Ind"},{"key":"10.1016\/j.eclinm.2024.102589_bib89","first-page":"90+147","article-title":"Clinical treatment and symptom outcome analysis of Mycoplasma pneumoniae pneumonia in elderly women","volume":"13","author":"Shujuan","year":"2019","journal-title":"Womens Health Res"},{"issue":"20","key":"10.1016\/j.eclinm.2024.102589_bib90","first-page":"172","article-title":"Comparison of therapeutic effects between moxifloxacin and azithromycin in the treatment of adult Mycoplasma pneumonia","volume":"9","author":"Junxi","year":"2017","journal-title":"China Continuing Med Educ"},{"issue":"25","key":"10.1016\/j.eclinm.2024.102589_bib91","first-page":"69","article-title":"The efficacy of moxifloxacin in the treatment of adult mycoplasma pneumonia. Cardiovascular disease journal of integrated traditional Chinese and western","volume":"5","author":"Jianhua","year":"2017","journal-title":"Medicine (Electronic)"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102589_bib92","first-page":"145","article-title":"Comparison of the efficacy of moxifloxacin and azithromycin in the treatment of adult Mycoplasma pneumoniae pneumonia","volume":"18","author":"Xuelian","year":"2020","journal-title":"Contemp Med Forum"},{"key":"10.1016\/j.eclinm.2024.102589_bib93","first-page":"82","article-title":"Clinical evaluation of moxifloxacin in the treatment of adult Mycoplasma pneumoniae pneumonia","volume":"16","author":"Xiujun","year":"2021","journal-title":"Gems Health"},{"issue":"7","key":"10.1016\/j.eclinm.2024.102589_bib94","first-page":"128","article-title":"Clinical efficacy analysis of moxifloxacin in the treatment of adult Mycoplasma pneumonia","volume":"11","author":"Yanchun","year":"2016","journal-title":"China Pract Med"},{"issue":"20","key":"10.1016\/j.eclinm.2024.102589_bib95","first-page":"69+72","article-title":"Clinical efficacy analysis of moxifloxacin in the treatment of adult Mycoplasma pneumonia","volume":"18","author":"Huanhuan","year":"2020","journal-title":"Med Diet Health"},{"issue":"7","key":"10.1016\/j.eclinm.2024.102589_bib96","first-page":"102","article-title":"Clinical efficacy analysis of moxifloxacin in the treatment of adult Mycoplasma pneumonia","volume":"16","author":"Yu","year":"2018","journal-title":"J China Prescrip Drug"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102589_bib97","first-page":"103","article-title":"Clinical efficacy analysis of moxifloxacin in the treatment of adult Mycoplasma pneumonia","volume":"15","author":"Zhijun","year":"2018","journal-title":"J\u00a0North Pharm"},{"issue":"2","key":"10.1016\/j.eclinm.2024.102589_bib98","first-page":"83","article-title":"Clinical study of moxifloxacin in the treatment of adult mycoplasma pneumonia","volume":"44","author":"Kuan","year":"2021","journal-title":"Heilongjiang Med Pharm"},{"issue":"16","key":"10.1016\/j.eclinm.2024.102589_bib99","first-page":"72","article-title":"Analysis of the efficacy of moxifloxacin in the treatment of adult Mycoplasma pneumonia","volume":"38","author":"Liangyu","year":"2022","journal-title":"Chinese Commun Doctors"},{"issue":"12","key":"10.1016\/j.eclinm.2024.102589_bib100","first-page":"171+175","article-title":"Discussion on the improvement of clinical symptoms in patients with adult Mycoplasma pneumonia treated with moxifloxacin","volume":"7","author":"Zhixin","year":"2020","journal-title":"J\u00a0Pract Gynecol Endocrinol"},{"issue":"21","key":"10.1016\/j.eclinm.2024.102589_bib101","first-page":"79","article-title":"Clinical observation of moxifloxacin in the treatment of Mycoplasma pneumonia","volume":"22","author":"Xia","year":"2015","journal-title":"China Modern Med"},{"issue":"35","key":"10.1016\/j.eclinm.2024.102589_bib102","first-page":"150","article-title":"Clinical observation of moxifloxacin in the treatment of Mycoplasma pneumonia","volume":"8","author":"Zhiping","year":"2016","journal-title":"China Continuing Med Educ"},{"issue":"34","key":"10.1016\/j.eclinm.2024.102589_bib103","first-page":"143","article-title":"Observation on the clinical efficacy of moxifloxacin in the treatment of Mycoplasma pneumonia","volume":"9","author":"Yuxian","year":"2012","journal-title":"Med Innov China"},{"issue":"19","key":"10.1016\/j.eclinm.2024.102589_bib104","first-page":"176","article-title":"Clinical observation on the treatment of 42 cases of adult mycoplasma pneumonia with levofloxacin","volume":"7","author":"Yaping","year":"2012","journal-title":"China Pract Med"},{"issue":"43","key":"10.1016\/j.eclinm.2024.102589_bib105","doi-asserted-by":"crossref","DOI":"10.3346\/jkms.2018.33.e268","article-title":"Therapeutic efficacy and safety of prolonged macrolide, corticosteroid, doxycycline, and levofloxacin against macrolide-unresponsive mycoplasma pneumoniae pneumonia in children","volume":"33","author":"Ha","year":"2018","journal-title":"J\u00a0Korean Med Sci"},{"issue":"12","key":"10.1016\/j.eclinm.2024.102589_bib106","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1093\/cid\/cis784","article-title":"Rapid effectiveness of minocycline or doxycycline against macrolide-resistant Mycoplasma pneumoniae infection in a 2011 outbreak among Japanese children","volume":"55","author":"Okada","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.eclinm.2024.102589_bib107","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1002\/ppul.26426","article-title":"Safety study of moxifloxacin in children with severe refractory Mycoplasma pneumoniae pneumonia","volume":"58","author":"He","year":"2023","journal-title":"Pediatr Pulmonol"},{"issue":"5","key":"10.1016\/j.eclinm.2024.102589_bib108","first-page":"1025","article-title":"Safety and efficacy analysis of levofloxacin and doxycycline in the treatment of refractory Mycoplasma pneumonia in children","volume":"19","author":"Xinru","year":"2021","journal-title":"Central South Pharm"},{"issue":"3","key":"10.1016\/j.eclinm.2024.102589_bib109","first-page":"380","article-title":"Clinical analysis of 71 cases of adult mycoplasma pneumonia","volume":"22","author":"Weihua","year":"2013","journal-title":"Henan Med Res"},{"issue":"2","key":"10.1016\/j.eclinm.2024.102589_bib110","first-page":"151","article-title":"Retrospective study on 99 cases of adult Mycoplasma pneumoniae pneumonia","volume":"30","author":"Shanfeng","year":"2016","journal-title":"Med J Commun"},{"issue":"6","key":"10.1016\/j.eclinm.2024.102589_bib111","first-page":"491","article-title":"Cost-effectiveness analysis of gatifloxacin and azithromycin in the treatment of Mycoplasma pneumonia","volume":"24","author":"Shengyou","year":"2009","journal-title":"Northw Pharm J"},{"key":"10.1016\/j.eclinm.2024.102589_bib112","first-page":"762","article-title":"Comparison of therapeutic effects between gatifloxacin and azithromycin in the treatment of Mycoplasma pneumonia","volume":"7","author":"Zhou","year":"2007","journal-title":"J\u00a0Clin Pulmonary Med"},{"issue":"15","key":"10.1016\/j.eclinm.2024.102589_bib113","first-page":"48","article-title":"Comparison of clinical efficacy between moxifloxacin and azithromycin in the treatment of Mycoplasma pneumonia","volume":"6","author":"Yanzhe","year":"2009","journal-title":"Med Innov China"},{"issue":"10","key":"10.1016\/j.eclinm.2024.102589_bib114","first-page":"9","article-title":"The application value of doxycycline in severe Mycoplasma pneumoniae pneumonia in children","volume":"27","author":"Ying","year":"2021","journal-title":"J\u00a0Pediatr Pharm"},{"key":"10.1016\/j.eclinm.2024.102589_bib115","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2022.1069504","article-title":"Disproportionality analysis of quinolone safety in children using data from the FDA adverse event reporting system (FAERS)","volume":"10","author":"Kong","year":"2023","journal-title":"Front Pediatr"},{"issue":"9","key":"10.1016\/j.eclinm.2024.102589_bib116","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s40264-013-0089-8","article-title":"Tendon injury and fluoroquinolone use: a systematic review","volume":"36","author":"Stephenson","year":"2013","journal-title":"Drug Saf"},{"issue":"2","key":"10.1016\/j.eclinm.2024.102589_bib117","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1136\/ejhpharm-2018-001805","article-title":"Seizures and quinolone antibiotics in children: a systematic review of adverse events","volume":"27","author":"Neame","year":"2020","journal-title":"Eur J Hosp Pharm"},{"issue":"5","key":"10.1016\/j.eclinm.2024.102589_bib118","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.jpeds.2015.02.015","article-title":"No visible dental staining in children treated with doxycycline for suspected rocky mountain spotted fever","volume":"166","author":"Todd","year":"2015","journal-title":"J\u00a0Pediatr"},{"issue":"2","key":"10.1016\/j.eclinm.2024.102589_bib119","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/jcph.2358","article-title":"Long-term safety profiles of macrolides and tetracyclines: a systematic review and meta-analysis","volume":"64","author":"Waitayangkoon","year":"2023","journal-title":"J\u00a0Clin Pharmacol"},{"issue":"9","key":"10.1016\/j.eclinm.2024.102589_bib120","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1164\/rccm.200905-0808OC","article-title":"Efficacy of corticosteroids in community-acquired pneumonia: a randomized double-blinded clinical trial","volume":"181","author":"Snijders","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.eclinm.2024.102589_bib121","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ijantimicag.2017.02.027","article-title":"Killing kinetics of minocycline, doxycycline and tosufloxacin against macrolide-resistant Mycoplasma pneumoniae","volume":"50","author":"Morozumi","year":"2017","journal-title":"Int J Antimicrob Agents"},{"issue":"2","key":"10.1016\/j.eclinm.2024.102589_bib122","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/bph.12139","article-title":"Minocycline: far beyond an antibiotic","volume":"169","author":"Garrido-Mesa","year":"2013","journal-title":"Br J Pharmacol"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102589_bib123","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2023-061350","article-title":"Antibiotic exposure and dental health: a systematic review","volume":"152","author":"Ravindra","year":"2023","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.eclinm.2024.102589_bib124","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0173635","article-title":"Therapeutic efficacy of azithromycin, clarithromycin, minocycline and tosufloxacin against macrolide-resistant and macrolide-sensitive Mycoplasma pneumoniae pneumonia in pediatric patients","volume":"12","author":"Ishiguro","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.eclinm.2024.102589_bib125","series-title":"Red book: 2018 report of the committee on infectious diseases","first-page":"905","article-title":"Of pediatrics: tetracyclines","author":"American","year":"2018"},{"issue":"3","key":"10.1016\/j.eclinm.2024.102589_bib126","doi-asserted-by":"crossref","first-page":"e92","DOI":"10.1093\/jpids\/piy056","article-title":"Safety and tolerability of moxifloxacin in children","volume":"7","author":"Dixit","year":"2018","journal-title":"J\u00a0Pediatric Infect Dis Soc"},{"issue":"5","key":"10.1016\/j.eclinm.2024.102589_bib127","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s40272-022-00513-2","article-title":"Safety of quinolones in children: a systematic review and meta-analysis","volume":"24","author":"Li","year":"2022","journal-title":"Paediatr Drugs"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537024001688?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537024001688?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T21:50:18Z","timestamp":1760737818000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537024001688"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":127,"alternative-id":["S2589537024001688"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2024.102589","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness and safety of tetracyclines and quinolones in people with Mycoplasma pneumonia: a systematic review and network meta-analysis","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2024.102589","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102589"}}